Fig. 3 | Scientific Reports

Fig. 3

From: ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B

Fig. 3

Survival curve established by data obtained from KM-plot. (A) – the survival time of IDC patients with high expression of KAT6ACYT with regard to TNM IIA stage is lower than that of patients with low expression (p = 0.0427). (B) – among the patients with high KAT6ANUC expression in the Grade 3 group, the survival time is lower than in patients with low expression (p = 0.0387). C – TNM stage IIA patients with higher KAT6BNUC expression show a shorter survival time compared to those with low KAT6BNUC expressions (p = 0.0173).

Back to article page